Plate Nº 17 · recorded October 10, 2026
Neuroscience & MindReported finding
Old Dogs Could Help Scientists Crack Alzheimer's
A 2026 study in npj Dementia found aging dog brains accumulate the same abnormal proteins as human Alzheimer's brains — a natural model mice can't offer, with 99% of lab drugs failing in human trials.
By Marcus Bennett3 min read658 words
In brief
- 99% of Alzheimer's drugs that showed promise in the lab failed in human clinical trials
- Canine cognitive dysfunction affects more than a quarter of dogs over age 12
- The study, published in npj Dementia in 2026, found abnormal protein deposits in the same dog brain regions as in early human dementia
- Dogs with high protein deposits showed elevated blood levels of GFAP, a potential biomarker
- The Dog Aging Project is tracking more than 50,000 companion dogs over time
Ninety-nine percent of Alzheimer's drugs that look promising in the laboratory fail in human clinical trials — and a new study argues that aging pet dogs could help break that deadlock.
Published in the journal npj Dementia in 2026, the research shows that the brains of older dogs with dementia change in strikingly similar ways to the brains of people with early Alzheimer's disease. The authors say companion dogs offer a natural model of neurodegeneration that mice simply cannot provide.
Why haven't mice solved Alzheimer's?
Alzheimer's and other dementias are notoriously hard to study in people. The diseases typically begin developing two decades before symptoms prompt someone to see a clinician, which makes early diagnosis — and therefore early research — extremely difficult.
Mice, the standard laboratory stand-in, have a fundamental limitation: they do not naturally develop the buildup of misshapen proteins seen in human dementia. Researchers can genetically engineer mice to mimic parts of the disease, but no single mouse can reproduce every aspect of it. The consequences show in the data: 99% of Alzheimer's drugs that succeeded in the lab failed once they reached human trials.
Dogs, by contrast, develop dementia naturally. Canine cognitive dysfunction syndrome — a condition similar to human dementia — affects more than a quarter of dogs over age 12, and owners can report its symptoms through surveys.
What did the dog study find?
The research team, which included neurotoxicologist and study author, veterinary neurologist Stephanie McGrath, and neuropathologist Caitlin Latimer, examined donated brain samples from old dogs whose owners had consented to the donation after the animals died naturally or were euthanized to prevent further decline in their quality of life.
Using the same laboratory analysis methods applied to human samples, the researchers made two key findings:
- Dogs with canine cognitive dysfunction had abnormal protein deposits in the same brain regions affected in people with early dementia.
- Dogs with high levels of these deposits also had unusually elevated blood levels of a protein called glial fibrillary acidic protein, or GFAP.
GFAP is normally found in the blood only during brain injury or disease. That makes it a promising biomarker — a measurable biological indicator — that could help diagnose cognitive decline in dogs and, at the same time, offer clues about how dementia progresses in people.
The findings are preliminary in an important sense: the study examined brain samples from a relatively defined group of donated dogs, and the authors frame the work as highlighting the value of dogs as a research model rather than proving that dog-based testing will predict human drug outcomes. Much more validation lies ahead.
How do dogs fit into the bigger research picture?
The new study is not the only effort focused on canine aging. The Dog Aging Project, a long-term study of more than 50,000 companion dogs, is investigating the biological, genetic and environmental factors that influence how the whole body ages — brain included.
That project has developed a battery of canine cognitive tests that researchers can use to detect early changes in thinking and behavior before a dog shows obvious neurological symptoms. With that data, scientists can link pathological changes in the brain to behavioral changes as they unfold.
Understanding why some dogs — and some people — develop dementia while others stay sharp could open two doors at once: earlier detection of the disease, and new treatments designed for brains that age the way human brains actually do.
Why this matters
Most people know someone with Alzheimer's disease. Treatments exist for its symptoms, but a cure remains elusive. If dogs can serve as a faithful natural model of the disease process — accumulating the same misshapen proteins in the same brain regions, and reflecting that damage in blood markers like GFAP — researchers may finally gain a testing platform that translates to human medicine.
Old dogs, it turns out, might have a few new tricks to teach Alzheimer's researchers after all.
via Medical Xpress (Source)
More from Marcus Bennett
Nearby plates
- Alzheimer's Trials Boost Interest in Drugs That Target Tau
- Alzheimer's Drug Developers Accuse Trial Sites of Faking Data
- UK Launches £80m Challenge to Speed Up Dementia Diagnosis
- New Roadmap Aims to Make Brain Resilience Research More Inclusive
- Blood marker rises 21 years before Alzheimer's diagnosis in Down syndrome